Drug Interactions of Antihypertensives with Cardiac Anatomy, Hemodynamics, and Electrophysiological Properties: A Comprehensive Review
International Journal of Pharmaceutical Quality Assurance · 16.06.2026 · 17 (06)
DOI: 10.25258/ijpqa.17.6.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 16.06.2026. Verfasst von Nandita Agrawal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
This review aims to systematically evaluate clinically relevant drug interactions of major antihypertensive drug classes—angiotensin‑converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), beta‑blockers, calcium channel blockers (CCBs), and diuretics—with other cardiovascular and non‑cardiovascular drugs, focusing on their combined effects on cardiac anatomy, hemodynamic parameters, and cardiac electrophysiological properties. Materials and Methods: A structured literature review was performed using PubMed, NCBI Bookshelf (StatPearls), and major cardiology/pharmacology textbooks to identify original studies, reviews, and practice guidelines on antihypertensive drug interactions. Inclusion criteria were: English‑language publications (2000– 2026), studies reporting hemodynamic, echocardiographic, or electrocardiographic outcomes, and drug‑interaction studies involving ≥1 antihypertensive agent. Data were extracted on drug class, interacting agents, mechanism (pharmacokinetic vs pharmacodynamic), site of interaction (vascular bed, myocardium, conduction system), and clinical outcomes (BP, heart rate, QT interval, AV‑node conduction, myocardial mass, chamber size). For illustrative purposes, a hypothetical cohort dataset was constructed to simulate real‑world polypharmacy scenarios in hypertensive patients, allowing description of statistical testing methods.
Results
Pharmacokinetic interactions most commonly involve CYP3A4‑dependent metabolism, particularly with verapamil and diltiazem, which inhibit CYP3A4 and increase plasma levels of co‑administered substrates (e.g., statins, antiarrhythmics, immunosuppressants). Pharmacodynamic interactions include additive hypotension with vasodilator combinations (e.g., dihydropyridine CCB + alpha‑1 blocker), enhanced AV‑nodal blockade with beta‑blocker + verapamil/diltiazem, and QT‑prolongation when some antihypertensives (e.g., certain CCBs) are combined with QT‑prolonging antiarrhythmics or psychotropics. Nonsteroidal anti‑inflammatory drugs (NSAIDs) antagonize the antihypertensive effect of ACEIs, ARBs, and diuretics by inducing sodium retention and vasoconstriction, while also increasing the risk of renal dysfunction when combined with renin–angiotensin– aldosterone system (RAAS) inhibitors. Hemodynamically, beta‑blockers and RAAS inhibitors favorably reduce myocardial wall stress and left ventricular hypertrophy, whereas unbalanced vasodilators may transiently increase shear‑stress patterns in atherosclerotic segments.
Conclusion
Antihypertensive drug interactions profoundly influence cardiac structure, hemodynamics, and electrophysiology. Awareness of key pharmacokinetic (CYP3A4‑mediated) and pharmacodynamic (additive vasodilation, AV‑nodal blockade, volume‑related) interactions is essential for prescribing safely in hypertensive patients with polypharmacy. Tailoring combinations to underlying cardiac anatomy (e.g., LVH, chamber dilatation) and electrophysiological substrate (e.g., sinus node disease, QT‑interval drugs) reduces the risk of hypotension, bradyarrhythmias, and sudden cardiac events.
Zitieren
APA
Agrawal, N., Deka, S., & Goswami, D. (2026). Drug Interactions of Antihypertensives with Cardiac Anatomy, Hemodynamics, and Electrophysiological Properties: A Comprehensive Review. International Journal of Pharmaceutical Quality Assurance, 17(06). https://doi.org/10.25258/ijpqa.17.6.3
Vancouver
Agrawal N, Deka S, Goswami D. Drug Interactions of Antihypertensives with Cardiac Anatomy, Hemodynamics, and Electrophysiological Properties: A Comprehensive Review. International Journal of Pharmaceutical Quality Assurance. 2026;17(06). doi:10.25258/ijpqa.17.6.3
BibTeX
@article{Agrawal2026,
author = {Agrawal, Nandita and Deka, Saurav and Goswami, Dibyajyoti},
title = {Drug Interactions of Antihypertensives with Cardiac Anatomy, Hemodynamics, and Electrophysiological Properties: A Comprehensive Review},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {06},
doi = {10.25258/ijpqa.17.6.3}
}
EUVIMED